Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | TYR | P14679 | 2/20 | 0.45 |
| ▸ | FABP3 | P05413 | 1/20 | 0.44 |
| ▸ | FABP4 | P15090 | 1/20 | 0.44 |
| ▸ | RXRA | P19793 | 1/20 | 0.44 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.44 |
| ▸ | MIF | P14174 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | CA4 | P22748 | 2/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | RNASEH1 | O60930 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3141670 | 1.00 | KDM4E (0.57) | KDM4EMAPK1TYRFABP3FABP4 | |
| SCHEMBL29046248 | 0.89 | KDM4E (0.47) | KDM4EMAPK1NFKB1ALDH1A1GAA | |
| SCHEMBL3145961 | 0.87 | KDM4E (0.57) | KDM4EMAPK1TYRFABP3FABP4 | |
| SCHEMBL3145956 | 0.87 | KDM4E (0.57) | KDM4EMAPK1TYRFABP3FABP4 | |
| SCHEMBL28319094 | 0.85 | TYR (0.44) | KDM4EMAPK1TYRFABP3FABP4 | |
| E-Methyl Cinnamate SCHEMBL28810582 | 0.83 | KDM4E (0.51) | KDM4EMAPK1TYRRXRANR4A2 | |
| E-Methyl Cinnamate SCHEMBL28948986 | 0.83 | KDM4E (0.51) | KDM4EMAPK1TYRRXRANR4A2 | |
| SCHEMBL12597166 | 0.83 | KDM4E (0.57) | KDM4EMAPK1TYRRXRANR4A2 | |
| SCHEMBL157462 | 0.83 | ALDH1A1 (0.48) | KDM4EMAPK1TYRFABP3FABP4 | |
| SCHEMBL645927 | 0.83 | ALDH1A1 (0.48) | KDM4EMAPK1TYRFABP3FABP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 151 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230055665-A1 | DELIVERY CARRIER INTO CELL | ITO, KABUSIKIKAISYA (JP) | 2023-02-23 | — | — | US | claimed |
| EP-2874507-B1 | AQUEOUS TRANSPARENT OIL-IN-WATER EMULSION COMPRISING AN EMULSIFIED CAROTENOID | BASF SE (DE) | 2020-12-30 | — | — | EP | claimed |
| EP-3307395-B1 | SOLUBILISING AGENTS FOR UV SCREENING COMPOUNDS | ISP INVESTMENTS LLC (US) | 2020-08-05 | — | — | EP | claimed |
| EP-2485807-B1 | SUN-CARE COMPOSITIONS | ISP INVESTMENTS LLC (US) | 2019-07-03 | — | — | EP | claimed |
| EP-2687103-B1 | Process for manufacturing an aqueous transparent oil-in-water emulsion comprising a carotenoid and emulsion produced | BASF SE (DE) | 2019-05-22 | — | — | EP | claimed |
| EP-1595936-B1 | COMPOSITION FOR EXTERNAL USE | VITAMIN C60 BIORES CORP (JP) | 2011-10-19 | — | — | EP | claimed |
| US-12605315-B2 | External skin preparation | KAO CORPORATION (JP) | 2026-04-21 | — | — | US | disclosed |
| US-12551424-B2 | Oil-in-water type emulsification composition containing UV wavelength conversion substance | SHISEIDO COMPANY, LTD. (JP) | 2026-02-17 | — | — | US | disclosed |
| US-12440431-B2 | Cosmetic comprising ultraviolet wavelength conversion substance | SHISEIDO COMPANY, LTD. (JP) | 2025-10-14 | — | — | US | disclosed |
| US-12419818-B2 | External preparation | KAO CORPORATION (JP) | 2025-09-23 | — | — | US | disclosed |
| US-12409118-B2 | External skin preparation | KAO CORPORATION (JP) | 2025-09-09 | — | — | US | disclosed |
| US-20250255791-A1 | POWDER COSMETIC CONTAINING ULTRAVIOLET WAVELENGTH-CONVERTING SUBSTANCE, AND METHOD FOR PRODUCING SAME | SHISEIDO COMPANY, LTD. (JP) | 2025-08-14 | — | — | US | disclosed |
| US-20250152484-A1 | OIL-IN-WATER EMULSION SKIN PREPARATION FOR EXTERNAL USE | KAO CORPORATION (JP) | 2025-05-15 | — | — | US | disclosed |
| WO-2001091715-A2 | TOPICAL AGENT FOR DERMATOLOGICAL USE CONTAINING 4-HYDROXYPHENYL-ALPHA-D-GLUCOPYRANOSIDE | PENTAPHARM LTD. (CH) | 2001-12-06 | — | — | WO | disclosed |
| EP-1141111-A1 | GEL COMPOSITIONS | Penreco (US) | 2001-10-10 | — | — | EP | disclosed |
| WO-2001024768-A2 | MATERIAL COMPRISING AN ORGANIC UV-A FILTER AND METHOD FOR DISPLACING THE MAXIMUM ABSORPTION WAVELENGTH | L'OREAL (FR) | 2001-04-12 | — | — | WO | disclosed |
| WO-2000026285-A1 | GEL COMPOSITIONS | PENRECO (US) | 2000-05-11 | — | — | WO | disclosed |
| CN-1135767-A | Shield ultraviolet compounded particle and production method thereof and cosmetics thereof | KAO CORP (JP) | 1996-11-13 | — | — | CN | disclosed |
| EP-0721484-A1 | ULTRAVIOLET SHIELDING COMPOSITE FINE PARTICLES, METHOD FOR PRODUCING THE SAME, AND COSMETICS | Kao Corporation (JP) | 1996-07-17 | — | — | EP | disclosed |
| WO-1995009895-A1 | ULTRAVIOLET SHIELDING COMPOSITE FINE PARTICLES, METHOD FOR PRODUCING THE SAME, AND COSMETICS | KAO CORPORATION (JP) | 1995-04-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12605315-B2 | External skin preparation | TLR5, CUTA, TLR3 | KDM4E 1765/4885MAPK1 4508/4885TYR 282/4885 |
| US-12409118-B2 | External skin preparation | CUTA, RBP4, DSG1 | KDM4E 1990/4885MAPK1 4798/4885TYR 635/4885 |
| US-20230055665-A1 | DELIVERY CARRIER INTO CELL | CTSA, ATG4A, ATG7 | KDM4E 3872/4885MAPK1 4175/4885TYR 3775/4885 |
| US-12551424-B2 | Oil-in-water type emulsification composition containing UV wavelength conversion substance | PCNA, CD14, TP53 | KDM4E 1150/4885MAPK1 2017/4885TYR 83/4885 |
| US-20250152484-A1 | OIL-IN-WATER EMULSION SKIN PREPARATION FOR EXTERNAL USE | CUTA, NAPEPLD, LIPA | KDM4E 4099/4885MAPK1 4113/4885TYR 113/4885 |
| US-12419818-B2 | External preparation | CUTA, ALOX15, HSF1 | KDM4E 3201/4885MAPK1 1568/4885TYR 53/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.